We spoke recently with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and lobbying group for the ...

Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...

The company offers Humira, an injection for autoimmune and ... Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin ...

The latter segment covers GLP-1, insulin, and other protein-related products ... This growth was attributed to its ex-Humira platform, a drug collection in the company’s pharmaceutical portfolio.

From the discovery of therapeutic biologicals in the 1920s, such as Salvarsan and insulin, to the blockbuster drugs birthed in the 1990s, such as Lipitor and Humira, pharma has always been on a ...

The drugs listed included AbbVie’s Humira (adalimumab ... The White House already targeted the major insulin manufacturers, which have been in the spotlight over rising prices of the medicine ...

but the introduction of self-injectable and retail pharmacy biosimilars (e.g., insulin and Humira biosimilars) is expanding accessibility. This shift will increase adoption rates, particularly for ...

For a company to obtain interchangeability for a biosimilar, in most cases—excluding insulin products and products administered ... we're just starting to have some success and conversion of Humira to ...

ST. PAUL, Minn. — Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers following its 2018 lawsuit over unaffordable ...